THURSDAY, SEPTEMBER 21, 2017

Bacterial 'superglue' could speed vaccine creation

Synthetic biologists and an interdisciplinary team based at the University of Oxford recently created a bacterial superglue that researchers may be able to use to speed the development of vaccines. Read More »

Missouri scientists create influenza vaccine for infants

Scientists from the University of Missouri School of Medicine have used a natural protein to develop an influenza vaccine that could prevent babies under 6 months old from contracting the flu. Read More »

Gavi teams with Merck to purchase Ebola vaccine

Gavi, the Vaccine Alliance, and Merck Sharp & Dohme Corp. (MSD) have committed to supporting the purchase of an Ebola vaccine to protect people from outbreaks of the deadly disease. Read More »

Profectus BioSciences launches phase 1 clinical trial for Ebola vaccine

Profectus BioSciences Inc., a clinical-stage vaccine company that creates vaccines to prevent and treat infectious diseases and cancers, recently began its Phase 1 clinical trial to evaluate the immunogenicity and safety of the company’s Ebola virus. Read More »

US Agency for International Development initiates National Action Plan against drug-resistant TB

The U.S. Agency for International Development (USAID) recently initiated the White House's National Action Plan for Combatting Multidrug-Resistant Tuberculosis (MDR-TB). Read More »

Some patients develop corneal inflammation from chickenpox vaccine

Scientists from the University of Missouri School of Medicine recently discovered  there are rare cases where the varicella zoster virus vaccine, which is meant to protect people from chickenpox and shingles, causes corneal inflammation. Read More »

FDA extends GSK's Hib vaccine to full series

The Food and Drug Administration recently took steps to extend the HIBERIX vaccine from GlaxoSmithKline from just a booster dose to a full series to better protect people from Haemophilus influenzae type b. Read More »

India begins nationwide Pulse Polio program

Indian President Shri Pranab Mukherjee recently initiated the Pulse Polio program for 2016, ensuring children under 5 years old will receive polio drops to protect them from the disease. Read More »

Study reveals primed genes sustain immune system memory

Scientists at the University of Birmingham recently conducted a study that revealed the human body’s ability to prime genes to remember infections, giving the immune system a memory of earlier infections. Read More »

Genesee County's 2015 Legionnaires' Disease report is released

The Michigan Department of Health and Human Services recently published its 2015 Legionnaires’ Disease report, showing a rise in rates within Genesee County. Read More »

Antibodies from Ebola survivors may fight disease strains

A recent study from Vanderbilt University Medical Center and the University of Texas Medical Branch in Galveston (UTMB) shows that antibodies from Ebola survivors may be able to help treat the family of Ebola viruses in other patients. Read More »

Varying immune responses may impact West Nile virus

Researchers from Benaroya Research Institute at Virginia Mason in Seattle recently conducted a study that shows unusual, exaggerate immune responses can make West Nile virus infections more severe. Read More »

Scientists show efficiency of antiretroviral therapy for infants with HIV

Scientists in South Africa have surpassed missing data to show that antiretroviral therapy is effective in treating infants who have HIV infections. Read More »

UK program faces shortage of MenB vaccine for children

Health professionals in the United Kingdom recently reported that the nation is experiencing a shortage of private vaccinates for meninigitis B (MenB) for children. Read More »

Expanded health care coud decrease impact of TB care cost in China

A recent study published in the Infectious Diseases of Poverty journal shows that improving universal health care could decrease the catastrophic health expenditure (CHE) for China's low-income tuberculosis (TB) patients. Read More »

Global Fund receives $4 billion investment for malaria fight

The Global Fund recently received a new investment from the Bill & Melinda Gates Foundation and the United Kingdom for its fight against malaria. Read More »

Meningitis B vaccine may protect infants from MenW strain

A study recently published in the Emerging Infectious Diseases journal suggests that Bexsero, a routine meningitis B vaccine administered in the U.K., may protect infants from MenW, also called ST-11, a strain that is especially dangerous. Read More »

Many TB tests inaccurate for pregnant women with HIV

Many of the tests that are most commonly used to diagnose tuberculosis may be inaccurate for diagnosing approximately 50 percent of pregnant women who have HIV infections. Read More »

Potential single treatment for multiple Ebola strains

Scientists at Vanderbilt University, The University of Texas Medical Branch in Galveston, Integral Molecular Inc., and The Scripps Research Institute have found a new approach that may enable them to make a single treatment for several Ebola strains. Read More »

Research shows HIV makes protein that manipulates genes

Researchers from the University of Texas Southwestern Medical Center recently discovered that HIV makes a small protein that manipulates human genes so the virus can advance into AIDS. Read More »